Abstract
This prospective observational study evaluated preoperative predictors of CRPS outcomes 6 months following total knee arthroplasty (TKA). Participants were n=110 osteoarthritis patients (64.5% female) undergoing unilateral TKA with no prior CRPS history. Domains of negative affect (depression, anxiety, catastrophizing), pain (intensity, widespread pain, temporal summation of pain [TSP]), pain interference, sleep disturbance, and proinflammatory status (tumor necrosis factor-alpha [TNF-a]) were assessed preoperatively. CRPS outcomes at 6 week and 6 month follow-up included the continuous CRPS Severity Score (CSS) and dichotomous CRPS diagnoses (2012 IASP criteria). At 6 months, 12.7% of participants met CRPS criteria, exhibiting a “warm CRPS” phenotype. Six week CSS scores were predicted by greater preoperative depression, anxiety, catastrophizing, TSP, pain intensity, sleep disturbance, and TNF-a (p’s<.05). Provisional CRPS diagnosis at 6 weeks was predicted by higher preoperative TSP, sleep disturbance, and TNF-a (p’s<.05). CSS scores at 6 months were predicted by more widespread and intense preoperative pain, and higher preoperative TSP, pain interference, and TNF-a (p’s<.01). CRPS diagnosis at 6 months was predicted only by more widespread and intense pain preoperatively (p’s<.05). Risk for CRPS following TKA appears to involve preoperative central sensitization and inflammatory mechanisms. Preoperative negative affect is unlikely to directly influence long-term CRPS risk.
Keywords: total knee arthroplasty, CRPS, complex regional pain syndrome, inflammation, central sensitization, mechanisms
Introduction
Complex Regional Pain Syndrome (CRPS) is a chronic pain condition typically beginning in a single limb that is characterized by spontaneous pain, allodynia and hyperalgesia, edema, changes in skin temperature and color, altered sweating, and motor and trophic changes7. CRPS appears to have multiple interacting mechanisms, including central and peripheral sensitization, autonomic changes, enhanced inflammatory and immune activity, and altered limb representation in the brain6,7. Limited epidemiological work suggests CRPS disproportionately affects women and individuals in middle age17,66, and fracture and surgery appear to be two of the most common inciting events17,32,36,66. However, specific patient-level risk factors for CRPS following tissue trauma are not well understood. Identification of prospective risk factors for subsequent CRPS could help enhance understanding of CRPS risk mechanisms.
Clinical lore long held the belief that certain psychosocial characteristics, particularly elevated negative affect, increased risk for CRPS6. A comprehensive review of the cross-sectional research literature and at least one large prospective study of patients following fracture fail to support this clinical belief2,3. Nonetheless, a few prospective studies hint that psychological factors may be relevant for understanding mechanisms contributing to CRPS risk20,35, for example, via effects of negative affect-related catecholamine release on adrenergic CRPS mechanisms6,7,37. Additionally, some prospective studies suggest that CRPS, whether developing after fracture27,47,59 or in the postsurgical setting35,67, may be predicted by elevated pain intensity prior to CRPS onset (surgery) or shortly after injury (fracture). This is consistent with the central sensitization mechanisms believed to be involved in CRPS5,18,21,25,69, and the likely role for central sensitization in driving elevated pain intensity prior to CRPS onset49,78. Consistent with the role of inflammation in established CRPS, particularly early CRPS9,31,54,68, numerous findings that CRPS is associated with elevated levels of proinflammatory cytokines (particularly tumor necrosis factor-alpha; TNF-a)14,44,53,62,75,77 suggest that proinflammatory status could be another CRPS risk mechanism. Finally, female sex may increase risk of CRPS following injury47,65. In sum, while a few longitudinal studies have identified individual risk factors for CRPS, prior prospective work has not evaluated a comprehensive set of biopsychosocial factors that may increase CRPS risk following tissue trauma, despite the potential value for understanding mechanisms contributing to CRPS risk.
Although whether CRPS occurs following total knee arthroplasty (TKA) remains debated by some51, two prior studies using standardized diagnostic criteria have reported a CRPS incidence of up to 12% at 6 months following TKA35,42. The current project therefore used TKA as a model to prospectively test a comprehensive set of preoperative predictors of CRPS outcomes in the 6 months following TKA. The predictors tested addressed the domains of pain (pain intensity, extent of widespread pain, temporal summation of pain), negative affect (depression, anxiety, catastrophizing), sleep disturbance, function (pain interference), and proinflammatory status (TNF-a). We hypothesized that elevated levels on all of these preoperative measures would be associated longitudinally with higher levels of CRPS features and greater risk of meeting CRPS diagnostic criteria at 6 week and 6 month post-TKA follow-up.
Methods
Design
The current study used a mixed between/within-subjects longitudinal design that included assessment of pain, psychosocial phenotype measures, and cytokines at preoperative baseline, and assessment of CRPS-related outcome measures at 6-week and 6-month post-TKA follow-up. The current dataset is part of a larger project examining perioperative oxidative stress mechanisms of post-TKA pain (described elsewhere10).
Participants
Participants were individuals of both sexes, age 55 or greater, and scheduled to undergo unilateral TKA for treatment of degenerative knee joint changes and pain related to chronic osteoarthritis. Participants were recruited from the practices of the two orthopedic surgeon co-authors (G.P., A.S.) at Vanderbilt University Medical Center (VUMC). Recruitment was primarily carried out via in-person introductory presentations during a required pre-operative TKA education session by the research coordinator in accordance with IRB requirements. To address Covid-related changes in clinical procedures affecting later enrollees, some individuals were recruited via telephone calls by the research coordinator to patients scheduled to undergo TKA. Interested individuals were provided with study information, and if interested, were screened for eligibility, and then provided informed consent. All study procedures were approved by the VUMC Institutional Review Board. All participants were enrolled between August 2017 and June 2021. The targeted sample size (n=120) for the parent study was determined based on a power analysis indicating that this sample size would lead to >.80 power to detect associations between the oxidative stress measure (F2-isoprostanes) that was the primary focus of the project and continuous pain and CRPS outcomes.
Inclusion criteria for study participation were: 1) intact cognitive status and ability to provide informed consent (based on a Mini Mental State Examination score ≥24)28, 2) ability to read and write in English sufficiently to understand and complete study questionnaires, 3) age 55 years or older, 4) undergoing unilateral TKA, and 5) medical diagnosis of osteoarthritis. Exclusion criteria were: 1) a diagnosis of CRPS prior to undergoing TKA (by history or in the electronic health record), 2) undergoing TKA revision, 3) presence of lower extremity vascular disease, inflammatory or autoimmune disorders, or malignancy, and 4) presence of other medical conditions that in the opinion of the orthopedic surgeons would make a participant’s study participation unsafe. Participants received $200 for completing the full study.
The pool of potential participants (i.e., individuals attending the TKA education classes) was n = 985, and n = 303 were interested in the study and screened. Of these, n = 120 consented, with n = 7 subsequently failing screening (cognitive dysfunction, medical exclusions). The final sample was n = 113 (no participants withdrew or were lost to follow-up), with the final analyzed sample including all participants (n = 110) with data available regarding CRPS diagnosis at 6-month follow-up (n = 3 were missing data due to inability to carry out in person follow-up evaluations due to Covid-related study restrictions). Preoperative participant demographics are summarized in Table 1. The sample consisted of older adults who were primarily of non-Hispanic white race/ethnicity, and nearly 2/3 of the sample were female.
Table 1.
Preoperative demographic characteristics and predictors, and CRPS outcomes at follow-up.
Median (IQR) or n (%) (n = 110) |
|
---|---|
Demographic Characteristics: | |
Age (years) | 68.0 (9.0) |
Gender (% female) | 71 (64.5) |
Race/Ethnicity: | |
Non-Hispanic White | 106 (96.4) |
African-American | 4 (3.6) |
BMI | 30.9 (7.6) |
Diabetes | 22 (20.0) |
Preoperative Predictors: | |
CES-D | 18.0 (10.0) |
CATS | 12.0 (15.0) |
STAI | 30.0 (10.0) |
MBM | 4.0 (4.0) |
TSP | 2.0 (2.0) |
MPQ-2 | 1.8 (2.23) |
PROMIS Interf | 62.1 (8.8) |
PROMIS Sleep | 53.3 (13.1) |
TNF-a (pg/mL) | 1.49 (0.52) |
CRPS Diagnostic Outcomes: | |
Provisional CRPS Diagnosis at 6 Week FU | 69 (62.7) |
CRPS Diagnosis at 6 Month FU | 14 (12.7) |
Note: CES-D = Center for Epidemiological Studies-Depression Scale, CATS = Catastrophizing Scale, STAI = State Trait Anxiety Inventory, MBM = Michigan Body Map, TSP = Temporal Summation of Pain, MPQ-2 = McGill Pain Questionnaire-Short Form 2, PROMIS Interf = PROMIS Pain Interference (T score), PROMIS Sleep = PROMIS Sleep Disturbance (T Score), TNF-a = tumor necrosis factor-alpha, FU = Follow-Up.
Psychometric Measures
Pain.
Knee pain over the week preceding the preoperative assessment was assessed using the Short Form-McGill Pain Questionnaire 2 (MPQ-2)22,23. For purposes of the current study, only the MPQ-2 Total score was examined (0–10 scale). Participants additionally completed the Michigan Body Map (MBM), a validated measure that was used to assess the number of body regions in which persistent or recurrent pain was experienced in the 90 days preceding the preoperative assessment11. An 11-point NRS anchored with “no pain” and “worst possible pain” was also used to rate worst knee pain in the 24 hours preceding CRPS assessment at 6-month follow-up48.
Psychosocial Status
Depressive symptoms were assessed using the Center for Epidemiological Studies-Depression scale (CES-D; 20 item version), a widely used standardized measure of depressive symptoms validated for use in older populations4,39. The trait form of the State-Trait Anxiety Inventory (STAI) was used to measure anxiety symptoms72, with higher scores indicating greater tendency to experience anxiety symptoms. Pain catastrophizing was assessed using the Pain Catastrophizing Scale (PCS)73, a measure assessing the degree to which individuals have negative thoughts and feelings when experiencing pain.
Sleep Disturbance
Sleep disturbance was assessed using the PROMIS Sleep Disturbance – Short Form 8a, an instrument assessing sleep quality, sleep depth, and restoration associated with sleep over the past week79.
Function.
The PROMIS Short Form v1.0 - Pain Interference 8a scale (PROMIS Interference) was used to assess pain-related life interference over the past week1,64.
Assessment of Temporal Summation of Pain
Temporal summation of pain (TSP) is believed to be an index of enhanced spinal responsiveness to nociceptive stimuli (i.e., central sensitization)24. Elevated TSP has been reported previously in osteoarthritis samples similar to participants in the present work38,60. TSP to punctate mechanical stimuli was assessed using procedures based on Goodin et al.30. The stimulus used was a 100g monofilament, with this stimulus weight determined based on weights shown to elicit TSP in prior literature (e.g., ranging from 25g to 300g)30,52. A single stimulus was first applied for one second to the affected knee (4cm above the patella, 8cm towards the midline), with pain intensity rated using a 0–10 NRS (anchored with “no pain” and “worst possible pain”). Then, using the same procedures as above, a series of 10 punctate stimuli were delivered at a rate of one stimulus per second to the affected knee, with an NRS pain intensity rating then obtained to describe the highest pain intensity experienced. This procedure was repeated twice. The change in pain intensity between the first stimulus and the stimulus eliciting the highest pain rating (mean of the two trials) was used to index preoperative TSP in the affected knee (larger positive values indicated greater TSP).
Assessment of CRPS
To ensure standardized assessment of CRPS signs and symptoms, a CRPS database checklist like that used in our past multisite research was used32,33. This checklist presented a complete list of the signs and symptoms used to diagnose CRPS according to the 2012 IASP criteria (i.e., Budapest clinical criteria)33. All assessments were conducted by a single research coordinator (S.A.) based on written standardized procedures used in prior work33. This individual also underwent thorough in-person training in CRPS assessment conducted by a CRPS expert (R.N.H.). Objective temperature asymmetry between the affected and unaffected sides was assessed via infrared thermometry conducted 8cm towards midline at the level of the top and bottom of the incision (two readings at each location on each leg, all averaged), with an average bilateral asymmetry of 1.5°C or greater used as the criterion for asymmetric temperature. No attempt was made to distinguish between CRPS-Type I vs. Type II subtypes, given that diagnostic features are identical between the two.
To optimize statistical power for prediction of CRPS-related outcomes, the continuous CRPS Severity Score (CSS) was used34,36. The CSS was scored according to previously published procedures36. In brief, the CSS was calculated by summing the responses indicating presence/absence (coded 1/0) of each sign and symptom as recorded on the CRPS database checklist. The CSS therefore provides a continuous index of the extent of CRPS diagnostic signs and symptoms. The potential range of CSS scores was 0–16.
Based on prior work indicating that early CRPS is characterized predominantly by inflammatory features which may remit to an extent over time, we also calculated the Inflammatory Index as described in Bruehl et al.9 as a supplementary CRPS outcome. This index represented a sum (ranging from 0 to 6) of dichotomous values (coded 1/0 for present/absent) for three symptoms and three signs indicative of inflammation (red skin color, warmer skin temperature, and edema on the affected side, i.e., rubor, calor, and tumor as described in classical inflammation).
Finally, dichotomous CRPS diagnosis at 6 week and 6 month follow-up was determined for each participant based upon meeting the 2012 IASP symptom and sign criteria (i.e., at least 3 of 4 symptom categories positive and at least 2 of 4 sign categories positive)33. “Pain disproportionate to the inciting event” was not explicitly required for diagnosis for two reasons. First, at the 6-week follow-up, disproportionate pain was difficult to judge due to the possibility of ongoing tissue healing secondary to the TKA procedure. CRPS diagnostic status at this early follow-up should be considered provisional only, due to the possibility that CRPS features reflect delayed healing that will resolve and the fact that diagnostic criteria exclude a CRPS diagnosis if diagnostic symptoms can be attributed to another condition (i.e., ongoing postsurgical healing). Second, it was assumed that any significant ongoing pain 6 months following TKA would be considered disproportionate given that the TKA procedure had corrected the underlying osteoarthritis pain generator and acute healing should be largely resolved. Although CRPS diagnostic outcomes are less statistically powerful due to their dichotomous nature, they were judged to be valuable for generalizing results to the clinical CRPS population.
Assessment of Inflammatory Cytokines
Systemic levels of proinflammatory cytokines were assessed using a Meso Scale Diagnostics V-Plex Human Proinflammatory Panel employing electrochemiluminescent detection (Meso Scale Diagnostics, Rockville, MD). The current study focused on systemic levels of TNF-a as a biological indicator of pre-operative proinflammatory status and potential risk mechanism for CRPS41,44,46,62,81. Plasma samples (described below) were analyzed in duplicate and assays were performed per manufacturer protocol and read and analyzed on a QuickPlex SQ120 (Meso Scale Diagnostics, Rockville, MD). Assay results are expressed as the mean of these duplicate assays (in pg/mL). The decision to obtain blood samples for cytokine assays was not made until after the study was ongoing, and these samples were therefore available for only n=72 participants.
Procedure
After providing informed consent, a baseline preoperative assessment session was carried out by a research coordinator in the participant’s home shortly before the scheduled surgery date (median = 3.0 days prior to surgery). The assessment session included completion of a demographic questionnaire and the measures of pain, psychosocial status, and function described above, as well as assessment of TSP.
The anesthesia and postoperative care protocol is described in supplemental materials (Supplement 1). Blood draws for cytokine assays were performed on the day of TKA surgery in the operating room from the clinically-placed intravenous catheter. We collected 8 mL of blood after induction of anesthesia, but prior to incision or placement of the lower extremity tourniquet. Blood was drawn into anticoagulant EDTA tubes (lavender caps) with glutathione and butylated hydroxytoluene added. Samples were then immediately stored on ice, and quickly transported to the laboratory, centrifuged at 1000G at 4° C for 10 minutes, and plasma separated and stored in a cryovial at −80°C until analyzed as described above.
At 6 weeks (6–8 week window) and 6 months (24–28 week window) following the TKA procedure, the research coordinator conducted a follow-up assessment session in the participant’s home. During these follow-up sessions, a CRPS assessment was conducted using the CRPS database form and standardized procedures previously described.
Statistical Analysis
All statistical analyses were conducted using SPSS (IBM SPSS Statistics for Windows, Version 26.0. Armonk, NY). Participant demographics, preoperative pain and psychosocial measures, pre-operative levels of systemic TNF-a, and CRPS outcomes at both follow-ups are summarized in Table 1 using either percentages or medians (IQR). Nonparametric Spearman correlations were used to characterize unadjusted (zero-order) associations among the predictors evaluated and between potential predictors and CRPS outcomes at follow-up. To examine longitudinal associations between the hypothesized preoperative predictors and CRPS status at 6-week and 6-month post-TKA follow-up, we used generalized linear models (GLM). Inspection of the distributions of the CSS and Inflammation Index outcomes indicated that they were significantly non-normal (Kolmogorov-Smirnov tests, all p’s<.005). Both outcomes were a good fit with a Poisson distribution (all p’s > .27), so GLM analyses of these outcomes specified a Poisson distribution. GLM analyses of dichotomous CRPS diagnoses specified a binomial distribution. To reduce the potential for confounding, we controlled for participant age, sex, and body mass index (BMI) in each model. Unlike some prior work, female sex was not associated with CRPS measures in any model (all p’s >.35; details not reported). TNF-a levels were right-skewed in our data, so we conservatively applied log base 2 transformations to this measure prior to including it in analyses. We used a two-sided p<0.05 significance level to define statistical significance.
Results
CRPS Outcomes Following TKA
At the early 6 week follow-up assessment, a clinical presentation meeting CRPS diagnostic criteria was noted in 69 of 110 participants (62.7%). In most, this presentation was likely attributable to the effects of ongoing acute healing and would not merit a clinical diagnosis of CRPS, so this diagnosis is considered provisional. Among the n=69 participants meriting a provisional CRPS diagnosis at 6 weeks, n=10 (14.5%) continued to meet CRPS criteria at 6 month follow-up. An additional n=4 participants not meeting CRPS criteria at 6 weeks did meet criteria at 6 month follow-up. For the sample as a whole, the incidence of CRPS based on meeting diagnostic criteria at 6 month follow-up was 12.7% (14 of 110 participants).
Table 2 summarizes the characteristic features of CRPS in participants meeting versus not meeting CRPS criteria at 6-week (provisional CRPS) and 6 month follow-up. Given the higher confidence in CRPS diagnosis at 6 months post-TKA, only results for this timepoint are detailed below. Relative to participants not meeting CRPS criteria at 6 months, those experiencing CRPS were characterized by significantly more allodynia/hyperalgesia, temperature asymmetry (90% were warmer on the affected side), skin color asymmetry (with 50% displaying red skin color), sweating asymmetry, edema in the affected limb, and motor changes. Although worst pain intensity in the past 24 hours was significantly higher (3 times as high) in the CRPS group than in the non-CRPS group (p<.01), pain intensity was in the mild-moderate range for most (e.g., only n = 6 participants reported worst pain intensity ranging from 4/10–8/10). As expected, CSS values in the CRPS group (Median = 6; range 5–10) were significantly higher (p<.001) at 6 month follow-up than in the non-CRPS group (Median = 2; range 0–6). The CRPS group also displayed significantly higher (p<.001) scores on the Inflammation Index at 6 month follow-up (Median = 3; range = 1–5) than did the non-CRPS group (Median = 2; range = 0–3).
Table 2.
CRPS diagnostic features by CRPS status at follow-up.
6 Week Follow-Up | 6 Month Follow-up | |||
---|---|---|---|---|
| ||||
CRPS Diagnostic Features | Non-CRPS (n=41) |
Provisional CRPS (n = 69) |
Non-CRPS (n=96) |
CRPS (n = 14) |
Self-Reported Symptoms (% Yes): | ||||
Allodynia or Hyperalgesia | 27.5 | 53.6** | 13.5 | 64.3*** |
Temperature Asymmetry | 40.0 | 88.4*** | 16.7 | 71.4*** |
Skin Color Asymmetry | 17.5 | 55.1*** | 3.1 | 28.6*** |
Sweating Asymmetry | 0.0 | 1.4 | 0.0 | 7.1** |
Asymmetric Edema | 47.5 | 94.2*** | 27.1 | 71.4*** |
Trophic Changes | 5.0 | 8.7 | 8.3 | 14.3 |
Motor Changes | 65.0 | 97.1*** | 43.8 | 100.0*** |
Signs Observed on Exam (% Yes): | ||||
Hyperalgesia to Pinprick | 13.2 | 17.4 | 2.3 | 14.3* |
Allodynia | 17.9 | 29.0 | 8.0 | 21.4 |
Temperature Asymmetry | 59.0 | 92.8*** | 33.7 | 71.4** |
Skin Color Asymmetry | 5.1 | 52.2*** | 4.6 | 14.3 |
Sweating Asymmetry | 0.0 | 1.4 | 0.0 | 0.0 |
Asymmetric Edema | 56.4 | 87.0*** | 44.8 | 78.6* |
Trophic Changes | 2.6 | 13.0 | 6.9 | 14.3 |
Motor Changes | 28.2 | 59.4** | 13.8 | 57.1*** |
CSS (Median, IQR) | 4.0 (2.0) | 7.0 (3.0)*** | 2.0 (3.0) | 6.0 (3.0)*** |
Inflammation Index (Median, IQR) | 2.0 (2.0) | 4.0 (1.0)*** | 2.0 (1.0) | 3.0 (2.0)*** |
NRS Past 24 Hour Worst Pain (Median, IQR) | 2.0 (3.0) | 4.0 (3.0)* | 1.0 (2.0) | 3.0 (4.0)** |
p < .05
p <.01
p<.001
Note: CSS = CRPS Severity Score; NRS = numeric rating scale.
Zero-Order Correlations
Table 3 presents zero-order Spearman’s nonparametric correlations among the preoperative predictors evaluated. Unsurprisingly, negative affect-related constructs (depression, anxiety, catastrophizing) showed large intercorrelations. These constructs also showed generally large positive associations with pain intensity, pain interference, and sleep disturbance, although associations were somewhat smaller for anxiety. Extent of widespread pain showed small but significant positive associations with pain intensity, as well as anxiety, catastrophizing, and pain interference. Similarly, TSP displayed its largest (positive) association with pain intensity, but was also significantly associated positively with depression, catastrophizing, and sleep disturbance. Sleep disturbance was positively associated not only with negative affect as noted above, but also with pain intensity and interference. Finally, greater TNF-a alpha levels were associated significantly only with higher depression levels.
Table 3.
Zero-order Spearman’s nonparametric correlations among preoperative predictors.
Preoperative Predictor | CES-D | CATS | STAI | MBM | TSP | MPQ-2 | PROMIS Interf | PROMIS Sleep |
---|---|---|---|---|---|---|---|---|
CATS | 0.66*** | --- | --- | --- | --- | --- | --- | --- |
STAI | 0.53*** | 0.60*** | --- | --- | --- | --- | --- | --- |
MBM | 0.14 | 0.21* | 0.21* | --- | --- | --- | --- | --- |
TSP | 0.28** | 0.29** | 0.13 | 0.15 | --- | --- | --- | --- |
MPQ-2 | 0.57*** | 0.60*** | 0.20* | 0.24* | 0.30** | --- | --- | --- |
PROMIS Interf | 0.52*** | 0.62*** | 0.37*** | 0.22* | 0.12 | 0.56*** | --- | --- |
PROMIS Sleep | 0.52*** | 0.42*** | 0.38*** | 0.18† | 0.20* | 0.39*** | 0.38*** | --- |
TNF-a | 0.26* | 0.19 | 0.12 | 0.19 | 0.08 | 0.09 | 0.13 | 0.17 |
p<.10
p<.05
p<.01
p<.001
Note: Correlations for dichotomous CRPS diagnostic outcomes are the equivalent of point-biserial correlations. CES-D = Center for Epidemiological Studies-Depression Scale, CATS = Catastrophizing Scale, STAI = State Trait Anxiety Inventory, MBM = Michigan Body Map, TSP = Temporal Summation of Pain, MPQ-2 = McGill Pain Questionnaire-Short Form 2, PROMIS Interf = PROMIS Pain Interference (T score), PROMIS Sleep = PROMIS Sleep Disturbance (T Score), TNF-a = tumor necrosis factor-alpha.
Table 4 presents zero-order (unadjusted) Spearman’s nonparametric correlations between hypothesized preoperative predictors and CRPS-related outcome measures at follow-up. Higher scores on the CSS (a continuous measure of CRPS-related clinical features) at 6 week follow-up were associated with significantly higher preoperative baseline levels of depression, catastrophizing, trait anxiety, TSP, pain intensity (MPQ-2), and sleep disturbance. A similar positive association between preoperative TNF-a levels and CSS scores at 6 weeks approached significance as well. Higher preoperative depression, TSP, pain intensity, and sleep disturbance were also specifically associated with a significantly greater number of inflammatory features (Inflammation Index) at this early follow-up. Only elevated TSP and preoperative pain intensity were significantly associated with greater likelihood of a dichotomous provisional CRPS diagnosis at 6 weeks, with a similar nonsignificant trend for TNF-a.
Table 4.
Zero-order Spearman’s nonparametric correlations between preoperative predictors and CRPS-related outcome measures at follow-up.
Preoperative Predictor | CSS 6 Week FU | CSS 6 Month FU | Inflammation Index 6 Week FU | Inflammation Index 6 Month FU | Provisional CRPS Diagnosis 6 Week FU | CRPS Diagnosis 6 Month FU |
---|---|---|---|---|---|---|
CES-D | 0.20* | 0.10 | 0.22* | 0.14 | 0.08 | 0.03 |
CATS | 0.20* | 0.17† | 0.16 | 0.10 | 0.10 | 0.01 |
STAI | 0.19* | 0.08 | 0.12 | 0.05 | 0.12 | −0.01 |
MBM | 0.04 | 0.16 | −0.04 | −0.12 | 0.00 | 0.17† |
TSP | 0.25** | 0.22* | 0.25** | 0.10 | 0.27** | 0.12 |
MPQ-2 | 0.27** | 0.42*** | 0.20* | 0.27** | 0.15 | 0.20* |
PROMIS Interf | 0.12 | 0.07 | 0.11 | −0.08 | 0.00 | −0.05 |
PROMIS Sleep | 0.34*** | 0.17 | 0.30** | 0.12 | 0.23* | 0.03 |
TNF-a | 0.20† | 0.16 | 0.09 | 0.22† | 0.20† | 0.02 |
p<.10
p<.05
p<.01
p<.001
Note: Correlations for dichotomous CRPS diagnostic outcomes are the equivalent of point-biserial correlations. CES-D = Center for Epidemiological Studies-Depression Scale, CATS = Catastrophizing Scale, STAI = State Trait Anxiety Inventory, MBM = Michigan Body Map, TSP = Temporal Summation of Pain, MPQ-2 = McGill Pain Questionnaire-Short Form 2, PROMIS Interf = PROMIS Pain Interference (T score), PROMIS Sleep = PROMIS Sleep Disturbance (T Score), TNF-a = tumor necrosis factor-alpha, CSS = CRPS Severity Score, FU = Follow-Up.
Greater CSS scores as 6 month follow-up were associated significantly only with higher preoperative levels of TSP and pain intensity, although a similar nonsignificant trend for catastrophizing was noted. Higher preoperative pain intensity also was significantly associated with extent of inflammatory features at 6 month follow-up. A similar trend for TNF-a approached significance as well. Meeting CRPS diagnostic criteria at 6 month follow-up was significantly associated only with elevated preoperative pain intensity, although a similar nonsignificant trend for extent of recent widespread pain (MBM) was noted.
Preoperative Predictors of Continuous CSS Outcomes at Postoperative Follow-Up
GLM analyses (Poisson distribution) revealed numerous preoperative baseline predictors of CSS scores at 6 week follow-up when potential confounding influences of age, sex, and BMI were statistically controlled (Table 5). Greater preoperative levels of depression, catastrophizing, trait anxiety, TSP, pain intensity, sleep disturbance, and TNF-a were all significant prospective predictors of higher CSS scores at 6 week follow-up.
Table 5.
GLM analyses of prospective preoperative predictors of CRPS-related outcome measures at follow-up.
6-Week Follow-Up | 6-Month Follow-Up | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||||||
CSS | Inflammation Index | Provisional CRPS Diagnosis | CSS | Inflammation Index | CRPS Diagnosis | |||||||||||||
| ||||||||||||||||||
Preoperative Predictor | Beta | SE | P value | Beta | SE | P value | Beta | SE | P value | Beta | SE | P value | Beta | SE | P value | Beta | SE | P value |
| ||||||||||||||||||
CES-D | 0.011 | 0.006 | .043 | 0.010 | 0.007 | .153 | 0.016 | 0.029 | .573 | 0.007 | 0.008 | .365 | 0.007 | 0.010 | .499 | 0.010 | 0.042 | .801 |
CATS | 0.009 | 0.003 | .011 | 0.006 | 0.004 | .164 | 0.021 | 0.019 | .268 | 0.007 | 0.005 | .128 | 0.005 | 0.007 | .472 | 0.006 | 0.026 | .821 |
STAI | 0.008 | 0.004 | .032 | 0.006 | 0.005 | .266 | 0.024 | 0.024 | .304 | 0.003 | 0.006 | .636 | 0.002 | 0.008 | .811 | 0.000 | 0.031 | .996 |
MBM | 0.015 | 0.010 | .158 | 0.004 | 0.014 | .770 | 0.052 | 0.061 | .389 | 0.040 | 0.015 | .005 | −0.007 | 0.022 | .749 | 0.202 | 0.076 | .008 |
TSP | 0.072 | 0.028 | .009 | 0.064 | 0.036 | .081 | 0.473 | 0.174 | .007 | 0.113 | 0.040 | .005 | 0.030 | 0.053 | .572 | 0.238 | 0.208 | .253 |
MPQ-2 | 0.055 | 0.021 | .010 | 0.042 | 0.028 | .141 | 0.190 | 0.125 | .130 | 0.148 | 0.030 | <.001 | 0.092 | 0.041 | .023 | 0.362 | 0.160 | .023 |
PROMIS Interf | 0.007 | 0.006 | .174 | 0.008 | 0.007 | .255 | 0.018 | 0.028 | .515 | 0.043 | 0.007 | <.001 | −0.001 | 0.010 | .942 | 0.006 | 0.040 | .879 |
PROMIS Sleep | 0.014 | 0.004 | .001 | 0.013 | 0.006 | .018 | 0.068 | 0.026 | .007 | 0.011 | 0.006 | .075 | 0.008 | 0.008 | .358 | 0.014 | 0.032 | .663 |
TNF-a | 0.219 | 0.083 | .009 | 0.138 | 0.111 | .214 | 1.462 | 0.642 | .023 | 0.375 | 0.118 | .001 | 0.322 | 0.154 | .036 | 0.764 | 0.642 | .234 |
Note: Analyses of continuous CSS and Inflammation Index outcomes specified a Poisson distribution. Analyses of dichotomous CRPS diagnostic outcomes specified a binomial distribution. TNF-a values were log2 transformed to reduce the impact of outliers. Significant results are highlighted in bold text. CES-D = Center for Epidemiological Studies Depression Scale, CATS = Catastrophizing Scale, STAI = State Trait Anxiety Inventory, MBM = Michigan Body Map, TSP = Temporal Summation of Pain, MPQ-2 = McGill Pain Questionnaire-Short Form 2, PROMIS Interf = PROMIS Pain Interference (T score), PROMIS Sleep = PROMIS Sleep Disturbance (T Score), TNF-a = tumor necrosis factor-alpha, CSS = CRPS Severity Score.
Similar GLM analyses revealed a number of preoperative baseline predictors of CSS scores at 6 month follow-up when potential confounds were statistically controlled. More widespread pain preoperatively (MBM) and higher preoperative levels of TSP, pain intensity, pain interference, and TNF-a were all significant prospective predictors of higher CSS scores at 6 month follow-up. In terms of specific inflammatory features at 6 months post-TKA, GLMs indicated that elevated preoperative pain intensity and proinflammatory status (TNF-a) both prospectively predicted higher Inflammatory Index values at 6 month follow-up.
Preoperative Predictors of Dichotomous CRPS Diagnosis at Postoperative Follow-Up
GLM analyses (binomial distribution) revealed that when controlling for potential confounding influences of age, sex, and BMI, elevated preoperative sleep disturbance as well as greater preoperative TSP and proinflammatory status (TNF-a) were each significant predictors of a provisional CRPS diagnosis at 6 week follow-up (Table 5). To quantify the predictive value of these measures in terms of diagnostic accuracy, we conducted exploratory analyses using Receiver Operating Characteristic curve analysis procedures, with the area under the curve (c-index) used as the model accuracy criterion. A c-index of 0.50 indicates chance prediction, with a c-index of 0.70 typically considered a good predictive model (i.e., 70% of cases classified correctly). None of the individual predictors showed good accuracy for predicting CRPS diagnosis at 6 weeks (Sleep Disturbance = 0.64, TSP = 0.66, TNF-a = 0.61). After appropriate Z transformations for each individual measure, combined predictors were then evaluated for comparison to the univariate models. The combination of sleep disturbance and TSP led to a modest increase in predictive accuracy (an additional 3% of cases classified accurately) beyond the best single predictor, TSP (c-index = 0.69). The addition of TNF-a to this combined model notably increased the percentage of cases classified correctly (an additional 8%) and led to a good predictive model (c-index = 0.77).
GLM analyses similar to those above regarding longer-term CRPS outcomes indicated that only more widespread pain preoperatively (MBM) and elevated preoperative pain intensity were significant predictors of dichotomous CRPS diagnosis at 6 month follow-up (Table 5). In ROC analyses, inspection of c-index values indicated that none of the individual predictors showed good accuracy for predicting CRPS diagnosis at 6 months, although preoperative pain intensity approached this criterion (MBM = 0.62, pain intensity = 0.68). The combination of these two measures (Z-transformed) produced little increase in predictive accuracy (an additional 1% of cases classified accurately; c-index = 0.69) beyond the best single predictor, pain intensity.
Discussion
Relatively few longitudinal studies have evaluated risk factors for CRPS, with all focusing on a narrow range of predictors2,20,27,35,47,59,67. We examined a more comprehensive set of preoperative biopsychosocial risk factors regarding prospective associations with CRPS-related outcomes with the goal of enhancing understanding of CRPS risk mechanisms. CRPS outcomes at 6 months post-TKA most clearly reflect the clinical condition of CRPS, because by this point it is difficult to attribute ongoing CRPS-related features to acute healing. Results revealed a number of preoperative predictors of extent of CRPS clinical features (CSS scores) at 6 month follow-up, including more widespread preoperative pain and higher preoperative pain intensity and pain interference, higher temporal summation of pain (TSP), and higher levels of the proinflammatory cytokine TNF-a. Less statistically powerful analyses of CRPS diagnostic status at 6 month follow-up indicated that only presence of more widespread and more intense pain preoperatively were significant predictors. Incidence of CRPS based on the 2012 IASP criteria at 6 months postoperatively in the current study (12.7%) was quite similar to 6 month CRPS incidence in two prior TKA studies35,42.
Viewed within a mechanistic context, our results suggest that elevated preoperative levels of central sensitization and inflammation may identify patients likely to experience more extensive CRPS-related features 6 months following TKA. Central sensitization mechanisms are supported by the predictive utility of more intense and widespread pain preoperatively, both of which are linked to central sensitization16,40,70,78,80. Our findings are entirely consistent with previous prospective studies reporting that elevated pain intensity pre-surgery or shortly after injury predicts subsequent CRPS27,35,47,59,67. Intriguingly, results of one recent large retrospective electronic health record study suggested that presence of fibromyalgia, a condition characterized by widespread pain, may be a risk factor for CRPS56. Findings that preoperative TSP predicts CRPS features at follow-up more directly argue for involvement of central sensitization in CRPS risk, given that TSP is an accepted laboratory index of central sensitization24. The importance of central sensitization mechanisms is further supported by prior work indicating that central sensitization is detectable in patients once CRPS is established25,69. Although central sensitization mechanisms are implicated in the current findings, prior work in osteoarthritis patients15,57 suggests that elevated preoperative pain intensity in the current sample could also in part reflect peripheral sensitization mechanisms known to be involved in CRPS76. Finally, findings that more widespread and intense pain preoperatively not only predict extent of CRPS features but also predict dichotomous CRPS diagnosis at 6 months post-TKA further highlight the importance of central sensitization mechanisms in CRPS risk.
The present study also found that higher preoperative levels of TNF-a, a key proinflammatory cytokine, predict extent of CRPS clinical features at 6 month follow-up. This supports involvement of preoperative proinflammatory status in CRPS risk post-TKA. Notably, TNF-a was not associated with any pain phenotype variables at preoperative baseline, suggesting that CRPS predictive effects of this inflammatory marker were not simply due to baseline associations carrying forward to follow-up. Clinical relevance of these TNF-a findings to CRPS is highlighted by findings that anti-TNF-a interventions reduce CRPS symptoms26,45. A role for preoperative inflammatory status in CRPS risk is also consistent with prior work suggesting involvement of the nfKappaB pathway in CRPS risk18,43, mechanistic links between nfKappaB activation and proinflammatory cytokine release43,74, and evidence that CRPS following traumatic injury is related to differential DNA methylation in immune and inflammatory pathways8.
Results at 6 week follow-up, when CRPS diagnosis is only provisional due to ongoing acute healing, revealed an even larger set of predictors. Elevated preoperative pain intensity, TSP, and TNF-a levels again predicted greater extent of CRPS features at 6 weeks. Elevated depression, anxiety, catastrophizing, and sleep disturbance also predicted extent of CRPS features at 6 weeks. In terms of CRPS mechanisms, psychosocial features such as depression and anxiety may capture negative affect-related catecholaminergic activity12,37,55 that could interact with known autonomic mechanisms of CRPS as in proposed theoretical models6,7. For the less statistically powerful test predicting provisional dichotomous CRPS diagnosis at 6 weeks, elevated TSP, sleep disturbance, and TNF-a levels preoperatively all were significant longitudinal predictors. Similar to findings at 6 month follow-up, these results suggest a role for central sensitization (TSP) and inflammatory mechanisms (TNF-a) as risk factors for early postsurgical emergence of CRPS-related phenomena.
Considering the pattern of predictors of CRPS features at shorter versus longer-term follow-up, it is notable that while preoperative negative affect-related measures were predictors of CRPS features at 6 weeks, they were not predictors at 6 months. This is consistent with findings of one previous study examining CRPS post-TKA, which indicated that anxiety predicted meeting CRPS criteria at 1 month but not 6 month follow-up35. At 4–6 weeks postoperatively, CRPS is only a provisional diagnosis due to ongoing acute healing. Absence of predictive effects at 6-month follow-up in this and other prior TKA work, as well as negative findings in one large prospective post-fracture study2, indicate that negative affect is unlikely to be a risk factor for longer-term CRPS diagnosis.
One finding suggested that sleep disturbance may be a relevant but overlooked issue in understanding CRPS. At 6 week follow-up, only preoperative sleep disturbance predicted extent of inflammatory signs and symptoms, features contributing heavily to CRPS diagnosis at this time point. Such associations are consistent with recent work suggesting that sleep disturbance is associated with a proinflammatory state13,58,71. The current results indicate that sleep disturbance may warrant systematic evaluation in future CRPS studies. In contrast to the early follow-up period, extent of inflammatory features at 6 months was predicted only by preoperative pain intensity and TNF-a levels. Such findings are consistent with predictive results for CRPS-specific outcomes, again suggesting the potential importance of preoperative central sensitization and proinflammatory status.
Additional prospective work to replicate and generalize the current findings to other relevant populations (e.g., carpal tunnel surgery, fracture) is necessary. Although predictive model development was not the purpose of this study, the current results could help guide development of optimized clinical predictive algorithms. For example, inspection of the pattern of intercorrelations between predictors suggests some independence among the three variables predicting provisional CRPS diagnosis at 6 weeks (sleep disturbance, TSP, and TNF-a), with the largest proportion of shared variance between sleep disturbance and TSP (4%) and the lowest between TSP and TNF-a (< 1%). The potential impact of differing overlapping variance on predictive models can be seen through inspection of c-index values for various models. The addition of TNF-a to a combined model increased accuracy substantially more (8%) than did adding TSP to sleep disturbance (3%), due to the higher level of overlapping variance between the latter two. Moreover, addition of TNF-a moved model performance into the good prediction range. Similar examination of predictors of CRPS diagnosis at 6 months indicated nearly 6% shared variance between the widespread pain and pain intensity predictors identified, and as a result, a combined model produced only 1% better accuracy than pain intensity alone. If a replicated predictive model with good accuracy were developed, it could have clinically utility for identifying patients preoperatively at greater risk for developing CRPS. These individuals then could be monitored more closely for early signs of CRPS and possibly early intervention. For example, patients with emerging CRPS might benefit from corticosteroids, which some work suggests may be effective for CRPS in its early stages50,63.
Potential study limitations are noted. First, CRPS in the TKA population may be qualitatively different than CRPS in other settings. Although our CRPS subgroup at 6 months reflected individuals meeting standardized IASP diagnostic criteria, the relatively low pain intensity (median = 3/10) compared to the intense pain often noted by CRPS patients in the pain management setting was notable. The CSS value in those meeting CRPS criteria (median CSS = 6) was also found to be slightly lower than observed in pain management patients recently diagnosed with CRPS (CSS = 8.7)36. It is not inconceivable that apparent CRPS even 6 months following surgery might yet reflect delayed healing that will resolve without specific intervention. Whether the current results will generalize to predicting CRPS in other settings, such as fracture and traumatic injuries, remains to be demonstrated. Second, the sample consisted largely of non-Hispanic, white, older adults, nearly 2/3 of whom were female. Generalization to different demographic groups (younger, male, more diverse race/ethnicity) should be confirmed in subsequent work. Finally, the study was powered for testing perioperative oxidative stress effects on continuous long-term pain outcomes in the primary project and therefore may not have had sufficient power to detect all relevant CRPS predictive relationships.
In summary, more widespread and intense preoperative pain, and greater pain interference, TSP, and circulating TNF-a were prospectively associated with a greater number of CRPS diagnostic features 6 months post-TKA. Negative affect-related predictors identified at 6 week follow-up did not predict 6 month CRPS outcomes. Whether or not participants met CRPS criteria at 6 months was predicted by more intense and widespread pain preoperatively. The overall pattern of findings supports a role for central sensitization and inflammatory mechanisms in determining postoperative CRPS risk.
Supplementary Material
Highlights.
At 6 months following total knee arthroplasty (TKA), 12.7% of patients meet criteria for CRPS
More intense and widespread preoperative pain predicted CRPS diagnosis at 6 months post-TKA
Greater preoperative pain, temporal summation, and TNF-a predicted CRPS severity 6 months post-TKA
Preoperative central sensitization and proinflammatory status enhance risk for CRPS following TKA
PERSPECTIVE:
This article identifies preoperative predictors of CRPS features at 6 months following total knee arthroplasty, including more widespread pain and higher pain intensity, temporal summation of pain, pain interference, and tumor necrosis factor-alpha levels. Findings suggest the importance of central sensitization and inflammatory mechanisms in CRPS risk following tissue trauma.
Acknowledgements
The authors would like to express their appreciation to Alan Hendon and Dr. Jordan Ernst for their assistance on this project.
DISCLOSURES:
This work was supported by the National Institute of Health (R01AG048915, R01GM112871) and the National Center for Advancing Translational Sciences (UL1TR000445). The authors have no conflicts of interest to declare.
References
- 1.Amtmann DA, Cook KF, Jensen MP, Chen W-H, Choi SW, Revicki D, Cella D, Rothrock N, Keefe F, Callahan L, Lai J-S: Development of a PROMIS item bank to measure pain interference. Pain 150: 173–182, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Beerthuizen A, Stronks DL, Huygen FJ, Passchier J, Klein J, Spijker AV: The association between psychological factors and the development of complex regional pain syndrome type 1 (CRPS1)--a prospective multicenter study. Eur J Pain 15: 971–975, 2011. [DOI] [PubMed] [Google Scholar]
- 3.Beerthuizen A, van ‘t Spijker A, Huygen FJ, Klein J, de Wit R: Is there an association between psychological factors and the Complex Regional Pain Syndrome type 1 (CRPS1) in adults? A systematic review. Pain 145: 52–59, 2009. [DOI] [PubMed] [Google Scholar]
- 4.Berkman LF, Berkman CS, Kasl S, Freeman DH Jr, Leo L, Ostfeld AM, Cornoni-Huntley J, Brody JA: Depressive symptoms in relation to physical health and functioning in the elderly. Am J Epidemiol 124: 372–388, 1986 [DOI] [PubMed] [Google Scholar]
- 5.Birklein F, Künzel W, Sieweke N: Despite clinical similarities there are significant differences between acute limb trauma and complex regional pain syndrome I (CRPS I). Pain 93: 165–171, 2001 [DOI] [PubMed] [Google Scholar]
- 6.Bruehl S: An update on the pathophysiology of complex regional pain syndrome. Anesthesiology 113: 713–725, 2010 [DOI] [PubMed] [Google Scholar]
- 7.Bruehl S: Complex regional pain syndrome. BMJ 351: h2730, 2015 [DOI] [PubMed] [Google Scholar]
- 8.Bruehl S, Gamazon ER, Van de Ven T, Buchheit T, Walsh CG, Mishra P, Ramanujan K, Shaw A: DNA methylation profiles are associated with complex regional pain syndrome after traumatic injury. Pain 160: 2328–2337, 2019 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Bruehl S, Maihöfner C, Stanton-Hicks M, Perez RS, Vatine JJ, Brunner F, Birklein F, Schlereth T, Mackey S, Mailis-Gagnon A, Livshitz A, Harden RN: Complex regional pain syndrome: evidence for warm and cold subtypes in a large prospective clinical sample. Pain 157: 1674–1681, 2016 [DOI] [PubMed] [Google Scholar]
- 10.Bruehl S, Milne G, Schildcrout J, Shi Y, Anderson S, Shinar A, Polkowski G, Mishra P, Billings FT 4th: Oxidative stress is associated with characteristic features of the dysfunctional chronic pain phenotype. Pain 163(4):786–794, 2022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Brummett CM, Bakshi RR, Goesling J, Leung D, Moser SE, Zollars JW, Williams DA, Clauw DJ, Hassett AL: Preliminary validation of the Michigan Body Map. Pain 157: 1205–1212, 2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Charney DS, Woods SW, Nagy LM, Southwick SM, Krystal JH, Heninger GR: Noradrenergic function in panic disorder. J Clin Psychiatry 51:5–10, 1990. [PubMed] [Google Scholar]
- 13.Cho CH, Kim DH, Baek EH, Kim DH: Serum Levels of TNF-α Are Increased in Patients with Rotator Cuff Tear and Sleep Disturbance. Diagnostics (Basel) 11: 2215, 2021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Clark JD, Tawfik VL, Tajerian M, Kingery WS: Autoinflammatory and autoimmune contributions to complex regional pain syndrome. Mol Pain 14: 1744806918799127, 2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Clauw DJ: Diagnosing and treating chronic musculoskeletal pain based on the underlying mechanism(s). Best Pract Res Clin Rheumatol 29: 6–19, 2015. [DOI] [PubMed] [Google Scholar]
- 16.de la Coba P, Bruehl S, Moreno-Padilla M, Reyes Del Paso GA: Responses to slowly repeated evoked pain stimuli in fibromyalgia patients: evidence of enhanced pain sensitization. Pain Med 18: 1778–1786, 2017 [DOI] [PubMed] [Google Scholar]
- 17.de Mos M, de Bruijn AG, Huygen FJ, Dieleman JP, Stricker BH, Sturkenboom MC: The incidence of complex regional pain syndrome: a population-based study. Pain 129: 12–20, 2007. [DOI] [PubMed] [Google Scholar]
- 18.de Mos M, Laferriè re A, Millecamps M, Pilkington M, Sturkenboom MC, Huygen FJ, Coderre TJ: Role ofNFkappaB in an animal model of complex regional pain syndrome-type I (CRPS-I). J Pain 10: 1161–1169, 2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Dietz C, Reinhold AK, Escolano-Lozano F, Mehling K, Forer L, Kress M, Üçeyler N, Sommer C, Dimova V, Birklein F, Rittner HL: Complex regional pain syndrome: role of contralateral sensitisation. Br J Anaesth 127: e1–e3, 2021. [DOI] [PubMed] [Google Scholar]
- 20.Dilek B, Yemez B, Kizil R, Kartal E, Gulbahar S, Sari O, Akalin E: Anxious personality is a risk factor for developing complex regional pain syndrome type I. Rheumatol Int 32: 915–920, 2012. [DOI] [PubMed] [Google Scholar]
- 21.Dimova V, Herrnberger MS, Escolano-Lozano F, Rittner HL, Vlckova E, Sommer C, Maihöfner C, Birklein F: Clinical phenotypes and classification algorithm for complex regional pain syndrome. Neurology; 94: e357–e367, 2020. [DOI] [PubMed] [Google Scholar]
- 22.Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Peirce-Sandner S, Bhagwat D, Everton D, Burke LB, Cowan P: Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain 144: 35–42, 2009. [DOI] [PubMed] [Google Scholar]
- 23.Dworkin RH, Turk DC, Trudeau JJ, Benson C, Biondi DM, Katz NP, Kim M: Validation of the Short-form McGill Pain Questionnaire-2 (SF-MPQ-2) in acute low back pain. J Pain 16: 357–366, 2015. [DOI] [PubMed] [Google Scholar]
- 24.Eide PK: Wind-up and the NMDA receptor complex from a clinical perspective. Eur J Pain 4: 5–15, 2000. [DOI] [PubMed] [Google Scholar]
- 25.Eisenberg E, Chistyakov AV, Yudashkin M, Kaplan B, Hafner H, Feinsod M: Evidence for cortical hyperexcitability of the affected limb representation area in CRPS: a psychophysical and transcranial magnetic stimulation study. Pain 113: 99–105, 2005. [DOI] [PubMed] [Google Scholar]
- 26.Eisenberg E, Sandler I, Treister R, Suzan E, Haddad M: Anti tumor necrosis factor - alpha adalimumab for complex regional pain syndrome type 1 (CRPS-I): a case series. Pain Pract 13: 649–656, 2013. [DOI] [PubMed] [Google Scholar]
- 27.Farzad M, Layeghi F, Hosseini A, Dianat A, Ahrari N, Rassafiani M, Mirzaei H: Investigate the Effect of Psychological Factors in Development of Complex Regional Pain Syndrome Type I in Patients with Fracture of the Distal Radius: A Prospective Study. J Hand Surg Asian Pac Vol 23: 554–561, 2018. [DOI] [PubMed] [Google Scholar]
- 28.Folstein MF, Folstein SE, McHugh PR, Fanjiang G: Mini-Mental State Examination User’s Guide. Odessa, Psychological Assessment Resources, 2001. [Google Scholar]
- 29.Gademan MGJ, Van Steenbergen LN, Cannegieter SC, Nelissen RGHH, Marang-Van De Mheen PJ: Population-based 10-year cumulative revision risks after hip and kneearthroplasty for osteoarthritis to inform patients in clinical practice: a competing risk analysis from the Dutch Arthroplasty Register. Acta Orthop 92: 280–284, 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Goodin BR, Bulls HW, Herbert MS, Schmidt J, King CD, Glover TL, Sotolongo A, Sibille KT, Cruz-Almeida Y, Staud R, Fessler BJ, Redden DT, Bradley LA, Fillingim RB: Temporal summation of pain as a prospective predictor of clinical pain severity in adults aged 45 years and older with knee osteoarthritis: ethnic differences. Psychosom Med 76: 302–310, 2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Guo TZ, Offley SC, Boyd EA, Jacobs CR, Kingery WS: Substance P signaling contributes to the vascular and nociceptive abnormalities observed in a tibial fracture rat model of complex regional pain syndrome type I. Pain 108: 95–107, 2004. [DOI] [PubMed] [Google Scholar]
- 32.Harden RN, Bruehl S, Galer BS, Saltz S, Bertram M, Backonja M, Gayles R, Rudin N, Bhugra MK, Stanton-Hicks M: Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficiently comprehensive? Pain 83: 211–219, 1999. [DOI] [PubMed] [Google Scholar]
- 33.Harden NR, Bruehl S, Perez RSGM, Birklein F, Marinus J, Maihofner C, Lubenow T, Buvanendran A, Mackey S, Graciosa J, Mogilevski M, Ramsden C, Chont M, Vatine JJ: Validation of proposed diagnostic criteria (the “Budapest Criteria”) for Complex Regional Pain Syndrome. Pain 150: 268–274, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Harden NR, Bruehl S, Perez RSGM, Birklein F, Marinus J, Maihofner C, Lubenow T, Buvanendran A, Mackey S, Graciosa J, Mogilevski M, Ramsden C, Schlereth T, Chont M, Vatine JJ: Development of a severity score for CRPS. Pain 151: 870–876, 2010. [DOI] [PubMed] [Google Scholar]
- 35.Harden NR, Bruehl S, Stanos S, Brander V, Chung OY, Saltz S, Adams A, Stulberg DS: Prospective examination of pain-related and psychological predictors of CRPS-like phenomena following total knee arthroplasty: a preliminary study. Pain 106: 393–400, 2003. [DOI] [PubMed] [Google Scholar]
- 36.Harden RN, Maihofner C, Abousaad E, Vatine JJ, Kirsling A, Perez RSGM, Kuroda M, Brunner F, Stanton-Hicks M, Marinus J, van Hilten JJ, Mackey S, Birklein F, Schlereth T, Mailis-Gagnon A, Graciosa J, Connoly SB, Dayanim D, Massey M, Frank H, Livshitz A, Bruehl S: A prospective, multisite, international validation of the Complex Regional Pain Syndrome Severity Score. Pain 158: 1430–1436, 2017. [DOI] [PubMed] [Google Scholar]
- 37.Harden RN, Rudin NJ, Bruehl S, Kee W, Parikh DK, Kooch J, Duc T, Gracely RH:Increased systemic catecholamines in complex regional pain syndrome and relationship to psychological factors: a pilot study. Anesth Analg 99: 1478–1485, 2004. [DOI] [PubMed] [Google Scholar]
- 38.Harden RN, Wallach G, Gagnon CM, Zereshki A, Mukai A, Saracoglu M, Kuroda MM, Graciosa JR, Bruehl S: The osteoarthritis knee model: psychophysical characteristics and putative outcomes. J Pain 14: 281–289, 2013. [DOI] [PubMed] [Google Scholar]
- 39.Haringsma R, Engels GI, Beekman AT, Spinhoven P: The criterion validity of the Center for Epidemiological Studies Depression Scale (CES-D) in a sample of self-referred elders with depressive symptomatology. Int J Geriatr Psychiatry 19: 558–563, 2004. [DOI] [PubMed] [Google Scholar]
- 40.Hattori T, Shimo K, Niwa Y, Tokiwa Y, Matsubara T: Association of Chronic Pain with Radiologic Severity and Central Sensitization in Hip Osteoarthritis Patients. J Pain Res 14: 1153–1160, 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Hensellek S, Brell P, Schaible HG, Bräuer R, Segond von Banchet G. The cytokine TNF-alpha increases the proportion of DRG neurones expressing the TRPV1 receptor via the TNFR1 receptor and ERK activation. Mol Cell Neurosci 2007; 36: 381–391. [DOI] [PubMed] [Google Scholar]
- 42.Hernigou J, Valcarenghi J, Callewier A, Sohm L, Decottenier V, Ledoux A, Kyriakidis T, Bath O: Prospective randomized study of the vitamin C effect on pain and complex pain regional syndrome after total knee arthroplasty. Int Orthop 45: 1155–1162, 2021. [DOI] [PubMed] [Google Scholar]
- 43.Hettne KM, de Mos M, de Bruijn AG, Weeber M, Boyer S, van Mulligen EM, Cases M, Mestres J, van der Lei J: Applied information retrieval and multidisciplinary research: new mechanistic hypotheses in complex regional pain syndrome. J Biomed Discov Collab 2: 2, 2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Huygen FJ, De Bruijn AG, De Bruin MT, Groeneweg JG, Klein J, Zijlstra FJ: Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm 11: 47–51, 2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Huygen FJ, Niehof S, Zijlstra FJ, van Hagen PM, van Daele PL: Successful treatment of CRPS 1 with anti-TNF. J Pain Symptom Manage 27: 101–103, 2004. [DOI] [PubMed] [Google Scholar]
- 46.Idriss HT, Naismith JH: TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech 50: 184–195, 2000. [DOI] [PubMed] [Google Scholar]
- 47.Jellad A, Salah S, Ben Salah Frih Z: Complex regional pain syndrome type I: incidence and risk factors in patients with fracture of the distal radius. Arch Phys Med Rehabil 95: 487–492, 2014. [DOI] [PubMed] [Google Scholar]
- 48.Jensen MP, Turner JA, Romano JM, Fisher LD: Comparative reliability and validity of chronic pain intensity measures. Pain 83: 157–162, 1999. [DOI] [PubMed] [Google Scholar]
- 49.Ji RR, Woolf CJ: Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis 8: 1–10, 2001. [DOI] [PubMed] [Google Scholar]
- 50.Kalita J, Vajpayee A, Misra UK: Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: a randomized controlled trial. QJM 99: 89–95, 2006. [DOI] [PubMed] [Google Scholar]
- 51.Kosy JD, Middleton SWF, Bradley BM, Stroud RM, Phillips JRA, Toms AD: Complex Regional Pain Syndrome after total knee arthroplasty is rare and misdiagnosis potentially hazardous-prospective study of the new diagnostic criteria in 100 patients with no cases identified. J Knee Surg 31: 797–803, 2018. [DOI] [PubMed] [Google Scholar]
- 52.Kurien T, Arendt-Nielsen L, Petersen KK, Graven-Nielsen T, Scammell BE: Preoperative Neuropathic Pain-like Symptoms and Central Pain Mechanisms in Knee Osteoarthritis Predicts Poor Outcome 6 Months After Total Knee Replacement Surgery. J Pain 19:1329–1341, 2018. [DOI] [PubMed] [Google Scholar]
- 53.Lenz M, Üçeyler N, Frettlöh J, Höffken O, Krumova EK, Lissek S, Reinersmann A, Sommer C, Stude P, Waaga-Gasser AM, Tegenthoff M, Maier C: Local cytokine changes in complex regional pain syndrome type I (CRPS I) resolve after 6 months. Pain 154: 2142–2149, 2013. [DOI] [PubMed] [Google Scholar]
- 54.Li WW, Sabsovich I, Guo TZ, Zhao R, Kingery WS, Clark DJ: The role of enhanced cutaneous IL-1beta signaling in a rat tibia fracture model of complex regional pain syndrome. Pain 144: 303–313, 2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Light KC, Kothandapani RV, Allen MT: Enhanced cardiovascular and catecholamine responses in women with depressive symptoms. Int J Psychophysiol 28: 157–166, 1998. [DOI] [PubMed] [Google Scholar]
- 56.Lipman MD, Hess DE, Werner BC, Deal DN: Fibromyalgia as a Predictor of Complex Regional Pain Syndrome After Distal Radius Fracture. Hand (N Y) 14: 516–522, 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Lluch E, Torres R, Nijs J, Van Oosterwijck J: Evidence for central sensitization in patients with osteoarthritis pain: a systematic literature review. Eur J Pain 18: 1367–1375, 2014. [DOI] [PubMed] [Google Scholar]
- 58.Matre D, Christensen JO, Mork PJ, Ferreira P, Sand T, Nilsen KB: Shift work, inflammation and musculoskeletal pain-The HUNT Study. Occup Med (Lond) 71: 422–427, 2021. [DOI] [PubMed] [Google Scholar]
- 59.Moseley GL, Herbert RD, Parsons T, Lucas S, Van Hilten JJ, Marinus J: Intense pain soon after wrist fracture strongly predicts who will develop complex regional pain syndrome: prospective cohort study. J Pain 15: 16–23, 2014. [DOI] [PubMed] [Google Scholar]
- 60.Neogi T, Frey-Law L, Scholz J, Niu J, Arendt-Nielsen L, Woolf C, Nevitt M, Bradley L, Felson DT; Multicenter Osteoarthritis (MOST) Study: Sensitivity and sensitisation in relation to pain severity in knee osteoarthritis: trait or state? Ann Rheum Dis 74: 682–688, 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Ng SM, Yin MXC, Chan JSM, Chan CHY, Fong TCT, Li A, So KF, Yuen LP, Chen JP, Chung KF, Chan CLW: Impact of mind-body intervention on proinflammatory cytokines interleukin 6 and 1β: A three-arm randomized controlled trial for persons with sleep disturbance and depression. Brain Behav Immun 99: 166–176, 2022. [DOI] [PubMed] [Google Scholar]
- 62.Parkitny L, McAuley JH, Di Pietro F, Stanton TR, O’Connell NE, Marinus J, van Hilten JJ, Moseley GL: Inflammation in complex regional pain syndrome: a systematic review and meta-analysis. Neurology 80: 106–17, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Perez RS, Zollinger PE, Dijkstra PU, Thomassen-Hilgersom IL, Zuurmond WW, Rosenbrand KC, Geertzen JH; CRPS I task force: Evidence based guidelines for complex regional pain syndrome type 1. BMC Neurol 10: 20, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.PROMIS Pain Interference Scoring Manual. Available at: http://www.healthmeasures.net/images/PROMIS/manuals/ PROMIS_Pain_Interference_Scoring_Manual.pdf. Accessed 3/23/21.
- 65.Roh YH, Lee BK, Noh JH, Baek JR, Oh JH, Gong HS, Baek GH: Factors associated with complex regional pain syndrome type I in patients with surgically treated distal radius fracture. Arch Orthop Trauma Surg 134: 1775–1781, 2014. [DOI] [PubMed] [Google Scholar]
- 66.Sandroni P, Benrud-Larson LM, McClelland RL, Low PA: Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. Pain 103: 199–207, 2003. [DOI] [PubMed] [Google Scholar]
- 67.Savaş S, İnal EE, Yavuz DD, Uslusoy F, Altuntaş SH, Aydın MA: Risk factors for complex regional pain syndrome in patients with surgically treated traumatic injuries attending hand therapy. J Hand Ther 31: 250–254, 2018. [DOI] [PubMed] [Google Scholar]
- 68.Schinkel C, Scherens A, Köller M, Roellecke G, Muhr G, Maier C: Systemic inflammatory mediators in post-traumatic complex regional pain syndrome (CRPS I) - longitudinal investigations and differences to control groups. Eur J Med Res 14: 130–135, 2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Sieweke N, Birklein F, Riedl B, Neundörfer B, Handwerker HO: Patterns of hyperalgesia in complex regional pain syndrome. Pain 80: 171–177, 1999. [DOI] [PubMed] [Google Scholar]
- 70.Sluka KA, Clauw DJ: Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience 338: 114–129, 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Sobolewska-Włodarczyk A, Włodarczyk M, Talar M, Wiśniewska-Jarosińska M, Gąsiorowska A, Fichna J: The association of the quality of sleep with proinflammatory cytokine profile in inflammatory bowel disease patients. Pharmacol Rep 73:1660–1669, 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Spielberger CD, Gorsuch RL, Lushene RE: The State-Trait Anxiety Inventory manual. Palo Alto, Consulting Psychologists Press, 1970. [Google Scholar]
- 73.Sullivan MJL, Bishop SR, Pivik J: The pain catastrophizing scale: development and validation. Psychol Assess 7: 524–532, 1995. [Google Scholar]
- 74.Tian B, Brasier AR: Identification of a nuclear factor kappa B-dependent gene network. Recent Prog Horm Res 58: 95–130, 2003. [DOI] [PubMed] [Google Scholar]
- 75.Uçeyler N, Eberle T, Rolke R, Birklein F, Sommer C: Differential expression patterns of cytokines in complex regional pain syndrome. Pain 132: 195–205, 2007. [DOI] [PubMed] [Google Scholar]
- 76.Vaneker M, Wilder-Smith OH, Schrombges P, de Man-Hermsen I, Oerlemans HM: Patients initially diagnosed as “warm” or “cold” CRPS 1 show differences in central sensory processing some eight years after diagnosis: A quantitative sensory testing study. Pain 115: 204–211, 2005. [DOI] [PubMed] [Google Scholar]
- 77.Walker S, Drummond PD: Implications of a local overproduction of tumor necrosis factor-α in complex regional pain syndrome. Pain Med 12: 1784–1807, 2011. [DOI] [PubMed] [Google Scholar]
- 78.Woolf CJ: Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011; 152(3 Suppl): S2–S15, 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Yu L, Buysse DJ, Germain A, Moul DE, Stover A, Dodds NE, Johnston KL, Pilkonis PA : Development of short forms from the PROMIS™ sleep disturbance and Sleep-Related Impairment item banks. Behav Sleep Med 10: 6–24, 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Zafereo J, Wang-Price S, Kandil E: Quantitative Sensory Testing Discriminates Central Sensitization Inventory Scores in Participants with Chronic Musculoskeletal Pain: An Exploratory Study. Pain Pract 21: 547–556, 2021. [DOI] [PubMed] [Google Scholar]
- 81.Zelová H, Hošek J: TNF-α signalling and inflammation: interactions between old acquaintances. Inflamm Res 62: 641–651, 2013. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.